A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. Cell-free expression is a field of expertise that is growing constantly. However, the future offers so much more. And Synthelis is both proud of the role it is playing in this industrial revolution and committed to developing its research to bring this fruit to bear in what will be the advent of synthetic biology.
Location: France, Auvergne-Rhône-Alpes, Grenoble
Employees: 1-10
Total raised: $827.14K
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | Crédit Agr... | ca-alpes-d... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.01.2014 | - | $827.14K | - |
Mentions in press and media 1
| Date | Title | Description |
| 18.06.2025 | Biocellis and General Inception announce equity partnership and strategic collaboration with Institut Pasteur. | Biocellis, an emerging player in biological research and in vitro diagnostic, announces equity partnership with General Inception and strategic collaboration with Institut Pasteur. This alliance will accelerate Biocellis' development and co... |